Chemed Files Definitive Proxy for Annual Meeting, Details Executive Compensation & Severance

summarizeSummary

Chemed filed its definitive proxy statement for the May 18, 2026 annual meeting, detailing executive compensation, including reduced annual incentives due to underperformance, a 0% payout for the TSR component of long-term awards, and substantial executive severance packages.

check_boxKey Events

• Annual Meeting Scheduled

  The Annual Meeting of Stockholders is set for May 18, 2026, with a record date of March 23, 2026, to vote on director elections, auditor ratification, and executive compensation.

• Executive Compensation Reflects Underperformance

  For 2025, annual non-equity incentive compensation for named executive officers was significantly below target (e.g., CEO at 60.4% of target) due to the company's underperformance against Adjusted EPS and Return on Assets goals.

• Long-Term Incentive Payouts Mixed

  Performance Share Units (PSUs) for the 2023-2025 period achieved a 124.1% payout for the Adjusted EPS target but a 0% payout for the Total Shareholder Return (TSR) component, reflecting poor relative performance against peers.

• Substantial Executive Severance Disclosed

  CEO Kevin J. McNamara has a potential severance package of $23.25 million in the event of a qualifying termination following a change in control, with other NEOs also having significant severance provisions.

auto_awesomeAnalysis

This definitive proxy statement outlines the agenda for Chemed's upcoming annual meeting, focusing on director elections, auditor ratification, and an advisory vote on executive compensation. The detailed compensation disclosures reveal that while annual non-equity incentives for 2025 were significantly below target due to the company's underperformance against Adjusted EPS and Return on Assets, the long-term performance share units (PSUs) for the 2023-2025 period resulted in a 0% payout for the Total Shareholder Return (TSR) component, indicating poor relative performance. Investors should note the substantial potential severance packages for executives, particularly the CEO's $23.25 million in a change-in-control scenario, which represents a material financial commitment. The CEO's pay ratio of 209:1 also highlights a significant disparity. These details are crucial for assessing corporate governance and executive alignment with shareholder interests, especially as the company trades near its 52-week low.